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Background: The existence of multiple chronic conditions in the same patient is a public health problem increas-
ingly recognized as relevant to health systems. Individuals with multimorbidity have additional health needs,
which imply a heavy burden in healthcare use. It is estimated that between 70% and 80% of the total health
expenditure is used with chronic conditions. Patients with multimorbidity are responsible for up to 75% of primary
care appointments. These patients are also high hospital users, with up to 14.6 times more risk of hospitalization.
Methods: This study analyses the association between healthcare use and multimorbidity in the Portuguese
population aged 25–74 years old. The association between socioeconomic variables and healthcare use was
studied, based on data from the first Portuguese Health Examination Survey using a logistic regression model,
stratified by sex and adjusted for socioeconomic confounding variables. Results: In patients with multimorbidity,
there was a greater use of primary healthcare consultations, medical or surgical specialist consultations and hos-
pitalizations. An association was established between female, older age groups and lower educational levels, and
increased healthcare use. When adjusted to socioeconomic variables, the likelihood of using healthcare services
can be as high as 3.5 times, when compared to patients without chronic conditions. Conclusion: Our results show a
greater healthcare use in multimorbidity patients, both in primary and hospital care. The availability of scientific
evidence regarding the use of healthcare services by multimorbidity patients may support health policy changes,
which could allow a more efficient management of these patients.
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Introduction
The presence of multiple chronic conditions coexisting in the sameindividual, and the expected increase in the diagnosis of these
conditions over the next years, is increasingly recognized as a fun-
damental problem of public health and healthcare in contemporary
societies.1,2
Individuals with multimorbidity will be more likely to have
increased health needs resulting in increased workload for health
services.3,4 Published studies on the burden of multimorbidity in
healthcare show different results. However, they all point to a
higher use of healthcare services by these patients. Treatment of
patients with chronic conditions accounts for up to 75% of all US
health spending budget4 and with an estimated average annual
amount spent on health by a patient with one chronic illness of
$850, rising to $6178 with three chronic illnesses and reaching $12
699 with four or more chronic illnesses.5 In Europe, these
pathologies account for 70–80% of health expenditure in countries
such as Denmark and are the cause of 8 out of 11 hospital
admissions in the UK.4
Patients with multimorbidity represent up to 78%3 of primary
care consultations with a mean of contacts ranging from 4.63 to
18.66 visits per year. These patients also show a high number of
prescriptions and hospital referrals, estimating an annual average
of 27.5 pharmacological prescriptions and 0.5 hospital referrals.6
The existence of multimorbidity is also of significant importance
in the use of hospital care, not only in outpatient visits but also in
the number of hospitalizations.4,7 In US hospitals, 66% of all
hospital discharges refer to patients with two or more chronic
conditions. These patients also present a longer average time of
hospitalization and higher associated costs.8 Similar data are
observed in Europe, with a link between the number of chronic
conditions and the number and duration of hospitalizations.9
Patients with three or more chronic conditions may be up to 14.6
times more likely to be hospitalized with a 25 times longer hospi-
talization time, when compared to patients without chronic
conditions.10
Mostly research on healthcare use by patients with multimorbidity
focuses on older adults.2,4,6,7,9 Multimorbidity becomes progressively
present with age, associated with increased mortality and reduced
functional capacity.11 Literature also shows the relationship between
underprivileged social situations, such as low literacy levels, and the
presence of multimorbidity.9,12 The incidence of multimorbidity
may occur between 10 and 15 years earlier in individuals with
worse socioeconomic profile.11 However, for younger population,
questions related to multimorbidity and associated healthcare use
have been overlooked. Evolution of medicine leads to sustainable
increase in average life expectancy, which also implies to live more
years with chronic conditions and longer need of care. Increased
knowledge of the epidemiology and impact of patients with
multimorbidity is particularly relevant in guiding the way
healthcare is organized and provided.
This study focused on the analysis of the association between
multimorbidity and healthcare use in the Portuguese population,
between 25 and 74 years, considering age, sex, education, income
and health regions as cofactors. The conclusions on this issue may
support the discussion on how to manage patients with
multimorbidity.
Methods
Study design
This study relies on data from the ‘Inque´rito Nacional de Sau´de com
Exame Fı´sico (INSEF)’.
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Detailed description of the sample design and methods of INSEF
has been published elsewhere.13 Briefly, INSEF is a cross-sectional,
observational, epidemiological study that collected data on a repre-
sentative probabilistic sample (n = 4911) of community-dwelling in-
dividuals aged 25–74 years old resident in Portugal in 2015.
The variables of interest were collected through Computer-
Assisted Personal Interview using the REDCap—Research
Electronic Data Capture software.14
Measures
The frequency of healthcare utilization was measured by three
questions:
‘During the past 4 weeks, how many times did you consult a GP
(general practitioner) or family doctor on your own behalf?’
‘During the past 4 weeks, how many times did you consult a
medical or surgical specialist on your own behalf?’
‘In the past 12 months how many times have you been admitted
to hospital as an inpatient, which is overnight or longer?’
Based on these questions three primary outcome variables were
defined: number of medical or surgical specialist consultations in the
last 4 weeks; number of primary care consultations in the last 4
weeks and number of hospitalizations in the last year. In addition,
binary measures of primary and hospital care utilization (yes/no)
were defined.
The multimorbidity variable was defined by the simultaneous
presence of two or more chronic conditions15 from a list of 20
pathologies,16 the selection of which was based on previous
National Health Surveys, the European Health Examination
Survey (EHES) as well as on the National Health Plan 2013–2016
(Supplementary table S1).
Variables of sociodemographic characterization were also selected,
namely sex, age group, education, adult-equivalized household
income (OECD modified equivalence scale)17 and health region.
Statistical analysis
To describe survey participants, counts and percentages were used
for categorical variables, means and standard deviation for
numerical variables. The Mann–Whitney and Kruskal–Wallis tests
were applied to compare number of medical or surgical specialist
consultations, number of primary care consultations and number of
hospitalizations between different population subgroups.
Factors associated with each of three types of healthcare use were
analysed using multivariable logistic regression models. Magnitude
of associations was measured by adjusted odds ratios (AOR).
Separate models were fitted for male and female and adjusted for
predisposing (age group and education), enabling (income and
region of residence) and need characteristics (multimorbidity)
variables chosen based on Andersen’s model of healthcare use.18
In the analysis of healthcare use for each additional chronic
condition, the number of medical or surgical specialist consultations
and the number of primary care consultations were used as a single-
dependent variable. In this analysis, the various chronic conditions
were grouped by their common pathophysiological mechanisms and
compared using a Kruskal–Wallis test. The limit of four or more
additional conditions was selected since it contained 94% of the
sample.
The statistical analysis was performed using the (SVY) package of
Stata 15.119 and the Survey Package of R.20 All statistical analyses
were performed using sampling weights, to provide nationally rep-
resentative results.
Ethical issues
The INSEF study received ethical approval from the Ethics
Commission of the Portuguese National Health Institute Doutor
Ricardo Jorge, the National Data Protection Authority (no 9348/
2010) and project partners’ Ethics Commissions. All participants
provided an informed consent form.
Results
The final sample size consisted in 4911 individuals, of which 47.5%
were males. The participants’ characteristics are described in table 1.
We found a multimorbidity prevalence of 38.3% confidence
interval (CI) 95% (35.4–41.3%). Patients with multimorbidity
reported higher healthcare use, with primary care consultations in
the previous 4 weeks of 0.28; mean medical or surgical specialist
consultations in the previous 4 weeks of 0.25 and hospitalization
mean in the previous year of 0.17. These values contrast with the
means presented by patients without chronic conditions, respect-
ively, 0.09; 0.12; and 0.11 and by patients with only one chronic
condition, respectively, 0.14; 0.18; and 0.16 (table 2).
A greater healthcare use, with statistically significant values for the
number of medical or surgical specialist consultations and primary
care consultations was observed for females, while no association
was verified between sex and number of hospitalizations. The
older age groups showed more frequent healthcare use with statis-
tically significant values for medical or surgical specialist consult-
ations and primary care consultations (table 2).
Socioeconomic gradients in hospital and primary care utilization
were observed. Population groups with higher income and higher
educational qualifications had more medical or surgical specialist
Table 1 Sociodemographic and health status characteristics of study
participants
Freqa (n)
Multimorbidity 2 or more chronic conditions 38.3% (1862)
Chronic conditions 0 chronic conditions 42.2% (2055)
1 chronic condition 19.4% (930)
2 chronic conditions 17.0% (838)
3 chronic conditions 10.4% (474)
4 chronic conditions 5.2% (264)
5 chronic conditions 3.0% (139)
6 chronic conditions 1.3% (68)
7 chronic conditions 0.7% (46)
8 chronic conditions 0.4% (21)
9 or more chronic conditions 0.3% (10)
Sex Male 47.5% (2646)
Female 52.5% (2245)
Age 25–34 18.3% (714)
35–44 23.5% (1135)
45–54 22.4% (1193)
55–64 19.9% (1098)
65–74 15.9% (771)
Education Cannot read or write/
elementary school
27.7% (1516)
Middle school 31.5% (1595)
Secondary school 21.4% (958)
Higher education 19.4% (838)
Incomeb Low 19.8% (1092)
Medium–low 18.4% (929)
Medium 20.4% (872)
Medium–high 19.7% (837)
High 21.7% (914)
Health region Norte 35.4% (777)
Centro 16.2% (706)
Lisboa e Vale do Tejo 34.8% (650)
Alentejo 4.6% (690)
Algarve 4.2% (644)
AR of Madeira 2.5% (695)
AR of Azores 2.3% (749)
aRelative frequencies weighted for the Portuguese population dis-
tribution by health region, sex and age group in 2015.
bQuintiles of adult-equalized household income from low (first
quintile) to high (fifth quintile).
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consultations and less primary care consultations, while populations
with lower incomes and lower educational qualifications had
opposite results (table 2).
In logistic regression models, the analysis was adjusted for age,
education, income and health region. Patients with multimorbidity
presented a 3.660 AOR 95% CI (2.316–5.797) in males and 2.590
AOR CI 95% (1.573–4.264) in females for primary care consult-
ations, compared to patients without chronic conditions.
Considering patients with one chronic condition as reference, for
primary care consultations, male patients with multimorbidity have
a 2.421 AOR 95% CI (1.321–4.439) and female patients a 1.729 OR
95% CI (1.054–2.837) (table 3).
For medical or surgical specialist consultations, the AOR of
patients with multimorbidity in relation to patients without
chronic conditions is 1.897 95% CI (1.068–3.372) in males and
2.869 95% CI (2.033–3.882) in females. Regarding the group of
patients with one chronic condition, the multimorbidity individuals
AOR is 1.630 95% CI (1.213–2.191) in the females. There is no
association in males (table 3).
For males with two or more conditions, the odds of reporting
hospitalizations in the past 12 months were 1.781 times as high
(AOR = 1.781, 95% CI 1.181–2.684) as for those without chronic
conditions. No association was observed for females (table 3).
The conditions with the greatest use of both primary and
specialist care consultations were musculoskeletal and mental
health groups (table 4).
Although there was an increased use of healthcare for each
additional chronic condition, data showed that this increased use
was not proportional to the greater number of conditions. However,
the group of patients with mental disorders had a higher number of
visits when accompanied by four or more additional chronic
conditions. On the other hand, patients with musculoskeletal
conditions had the lowest mean number of visits when they
present four or more additional chronic conditions.
Discussion
Using nationally representative data, this study found an association
between multimorbidity and healthcare use. Individuals with
multimorbidity reported more primary care visits, more hospital
visits and more hospitalizations than those without chronic
conditions.
Portugal health system combines a universal, financed mainly
through taxation, National Health Service (NHS), public and
private health insurance schemes and voluntary health insurance.
The Ministry of Health is responsible for central planning and
regulation, whereas the management of the NHS takes place at the
regional level, by the Regional Health Administrations. Public
primary care, which intends to be a gatekeeper to the system,
provides GP consultations. On the other hand, public hospitals are
responsible for almost all other medical or surgical specialist con-
sultations. The private sector, which has mainly a supplementary
role to universal NHS, has both GP and specialist consultations.21
The lack of a consensually accepted definition for multimorbidity
limits the comparison with other studies.22 The use of different
measurements for the same problem, using different population
samples, different age ranges and different number and type of
comorbidities, makes it difficult to extrapolate the results.23 The
data sources are also different, although there are several studies
Table 2 Healthcare use (primary care consultations, medical or surgical specialist consultations and hospitalizations) by sex, age group,
education, income, health region and presence of chronic conditions
Hospitalizations
(previous 12 months)
Medical or surgical
specialist consultations
(previous 4 weeks)
Primary care
consultations
(previous 4 weeks)
Mean (SD) P-value Mean (SD) P-value Mean (SD) P-value
Overall 0.13 (0.55) 0.17 (0.45) 0.18 (0.42)
Multimorbidity 0 chronic conditions 0.09 (0.33) <0.001 0.12 (0.39) <0.001 0.11 (0.35) <0.001
1 chronic condition 0.14 (0.76) 0.18 (0.43) 0.16 (0.41)
2 or more chronic conditions 0.17 (0.61) 0.25 (0.51) 0.28 (0.47)
Sex Male 0.14 (0.68) 0.564 0.14 (0.40) <0.05 0.15 (0.38) <0.001
Female 0.12 (0.39) 0.21 (0.49) 0.22 (0.45)
Age 25–34 0.14 (0.47) 0.122 0.15 (0.44) <0.001 0.13 (0.36) <0.001
35–44 0.08 (0.31) 0.15 (0.43) 0.15 (0.41)
45–54 0.16 (0.73) 0.16 (0.44) 0.17 (0.42)
55–64 0.18 (0.70) 0.22 (0.48) 0.23 (0.44)
65–74 0.12 (0.35) 0.23 (0.47) 0.26 (0.46)
Education Cannot read or
write/elementary school
0.13 (0.39) 0.311 0.17 (0.43) <0.001 0.26 (0.47) <0.001
Middle school 0.14 (0.44) 0.15 (0.43) 0.19 (0.44)
Secondary school 0.13 (0.60) 0.17 (0.43) 0.14 (0.36)
Higher education 0.14 (0.74) 0.25 (0.53) 0.11 (0.36)
Incomea Low 0.15 (0.47) 0.214 0.15 (0.43) <0.05 0.25 (0.47) <0.001
Medium–low 0.17 (0.74) 0.13 (0.36) 0.21 (0.47)
Medium 0.11 (0.37) 0.17 (0.40) 0.19 (0.41)
Medium–high 0.15 (0.77) 0.19 (0.48) 0.15 (0.36)
High 0.11 (0.36) 0.24 (0.53) 0.13 (0.38)
Health region Norte 0.12 (0.39) <0.05 0.21 (0.49) <0.05 0.23 (0.44) <0.001
Centro 0.11 (0.35) 0.12 (0.35) 0.16 (0.40)
Lisboa e Vale do Tejo 0.17 (0.77) 0.18 (0.45) 0.15 (0.39)
Alentejo 0.10 (0.34) 0.15 (0.46) 0.25 (0.58)
Algarve 0.12 (0.45) 0.17 (0.47) 0.19 (0.43)
AR of Madeira 0.08 (0.35) 0.15 (0.40) 0.12 (0.35)
AR of Azores 0.09 (0.09) 0.13 (0.36) 0.12 (0.34)
AR: autonomous region; SD: standard deviation.
aQuintiles of adult-equalized household income from low (first quintile) to high (fifth quintile).
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based on population surveys,24–26 most of the studies in this area are
based on clinical records.3,6,11,27
The greater use of healthcare among patients with multimorbidity
at both primary and hospital levels has been described by previous
studies in Europe.9 It is explained by the higher complexity of these
patients and their greater treatment needs. Although there is a
common trend, results vary by country depending on the
specificities of health systems.28 Ba¨hler et al.29 reported for Swiss
patients with multimorbidity, aged over 65 on average, 7.4
medical consultations per year in primary healthcare; 5.1 medical
or surgical specialist consultations; and 1.5 hospitalizations. In the
Netherlands average annual number of primary care visits of
patients with multimorbidity varied between 8.5430 and 4.8.6 In
Scotland, Glynn et al.4 reported an annual average of 6.88 primary
care consultations for patients with multimorbidity.
We observed an average of 0.28 primary care visits and 0.25
hospital visits over a 4 weeks period. Taking into account the
expected systematic rate of chronic condition consultations, as
well as the fact that the interviews conducted at INSEF took place
throughout the year, we can infer that the values found correspond
to an annual mean of 3.36 primary care consultations and 3 medical
or surgical specialist consultations. When we refer to hospitaliza-
tions, the annual values obtained—0.17—are also lower, in
comparison with literature.4,29 These lower than expected
frequencies may be explained by the data source—population-
based—and data collection methodology used, namely self-report.
Socioeconomic factors, age and sex are referred as important
cofactors of this association. Both the increase in age31 and the
existence of fragile socioeconomic conditions32 are associated with
higher prevalence of multimorbidity and healthcare use. One of the
reasons for the association between socioeconomic context and
multimorbidity may be the higher prevalence exposure to risk
factors for chronic conditions in populations with worse
socioeconomic conditions.29 In Portugal there is a greater use of
primary healthcare among less differentiated individuals, to the
detriment of medical or surgical specialist consultations, whereas
patients with higher income and higher educational qualifications
use more medical or surgical specialist consultations. This discrep-
ancy may be explained by a problem of healthcare access,33 with a
proportion of the population resorting directly to secondary care.
Fjær et al.34 reports a similar pattern of healthcare use at European
level, explaining it by the differentiated individuals greater availabil-
ity of resources, which allow them to go directly to a specialized
physician. As for gender, the healthcare use is usually described as
higher in women,23 which is in line with our results.
When adjusted for socioeconomic variables, we found that the
likelihood of patients with multimorbidity resorting to health
services remained high. For women and men with multimorbidity
the odds of primary care use were 3.5 times and 2.5 times as high
when for those without chronic conditions, respectively. The
hospital reality shows similar results, with the likelihood of
patients with multimorbidity using medical or surgical specialist
consultations, being approximately two times higher in women
and three times higher in men, also when compared to patients
without chronic conditions.
We found that healthcare use for each additional chronic
condition did not increase proportionately. The increase number
of chronic conditions resulted in a decreased number of consult-
ations per condition. This may be due to the similar pathophysio-
logical mechanisms between conditions, enhancing the treatments
performed, or the prioritization of certain chronic conditions to the
detriment of other.6
Patients with multimorbidity can benefit the most from integrated
healthcare.30 It is appropriate to reach a commitment with the patient
not only regarding his treatment plan, taking into account his expect-
ations and priorities, but also with the health professional who manages
the patient and is responsible for the communication and coordination
between the various services involved.35 Clinical governance could play
an important role as the conceptual framework of multichronicity
management, by promoting an integrated effort to improve quality,
patient satisfaction, activation and self-management, performance
monitoring, clinical risk management, education and learning.36 It is
also possible to intervene in medical practice by reformulating clinical
guidelines. The existing recommendations for different pathologies
should contain cross references, when there are synergistic or contra-
dictory effects between them, as well as identifying possible interactions
between the recommended treatment and common prescription
drugs.37
Table 4 Healthcare use by disease group and by additional chronic condition
Number of consultations
Additional chronic conditions
0, mean (SD) 1, mean (SD) 2, mean (SD) 3, mean (SD) 4 or more, mean (SD) P-value
Cardio and cerebrovascular conditionsa 0.29 (0.077) 0.44 (0.049) 0.46 (0.048) 0.60 (0.067) 0.67 (0.088) <0.001
Lung conditionsb 0.36 (0.129) 0.48 (0.201) 0.54 (0.122) 0.47 (0.235) 0.63 (0.140) 0.196
Gastric conditionsc 0.30 (0.148) 0.24 (0.073) 0.60 (0.149) 0.68 (0.175) 0.56 (0.083) <0.05
Musculoskeletal conditionsd 0.46 (0.105) 0.42 (0.067) 0.59 (0.063) 0.58 (0.055) 0.52 (0.079) <0.05
Mental health diseasese 0.44 (0.063) 0.44 (0.055) 0.58 (0.076) 0.57 (0.071) 0.80 (0.085) <0.001
Endocrinological pathologiesf 0.31 (0.059) 0.39 (0.058) 0.52 (0.035) 0.54 (0.084) 0.71 (0.074) <0.001
Renal conditionsg 1 (0.000) 1.56 (0.877) 0 0 0.51 (0.506) 
Chronic pain 0.41 (0.102) 0.53 (0.163) 0.81 (0.107) 0.57 (0.084) 0.79 (0.111) 0.228
Cancer 0.56 (0.135) 0.58 (0.167) 0.84 (0.229) 0.67 (0.150) 0.72 (0.196) 0.942
Allergic conditions 0.27 (0.044) 0.42 (0.118) 0.53 (0.093) 0.54 (0.131) 0.69 (0.144) <0.001
COPD: chronic obstructive pulmonary disease; HBP: high blood pressure.
aHBP; acute myocardial infarction; stroke and cardiac arrhythmia.
bAsthma and COPD.
cLiver cirrhosis; chronic hepatitis and gastric or duodenal ulcer.
dOsteoporosis; arthrosis and rheumatoid arthritis.
eDepression and chronic anxiety.
fDiabetes e hypercholesterolemia.
gChronic renal disease.
No test was performed due to the low frequencies found.
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Limitations and strengths
We point out that individuals who have accepted to participate in
INSEF may be the persons who use the services more often. In
addition, the data collection mode, based on National Register of
Health Service Users (RNU) and carried out in public healthcare
centres, may have left out users who favour private health services,
probably with higher socioeconomic status. Another important
limitation is the exclusion of individuals over 75 years old, which
may underestimate the prevalence of multimorbidity and the use of
health services. Furthermore, INSEF data were collected in
healthcare facilities, so older people with mobility problems may
be underrepresented. This may also result in underestimation of
health services frequency use. Taken into consideration that INSEF
data were collected through self-report, memory bias could be
present, which can underestimate our results.
The data collection methodology for chronic conditions does not
contemplate severity. The need for care and subsequent use of
services may be modified by the severity of the conditions. It
should also be mentioned that the questions that give rise to the
variables of primary care consultations and medical or surgical
specialist consultations refer only to the 4 weeks prior to the
collection of information, which may underestimate services use.
Sample size and questioning at different points of time can
mitigate this limitation. Statistically it was also possible to deal
with this limitation through the use of non-parametric tests. To
measure the association between multimorbidity and healthcare
use we have tried to model the number of consultations in
primary care or with medical or surgical specialist and the number
hospitalizations instead of binary variables, using more informative
models, like zero-inflated negative binomial regression.
Unfortunately, these models failed to converge for all the
outcomes in the study. For the sake of comparability, we have
opted for a more simple approach by adjusting a logistic
regression models for the binary outcomes.
The existence of a population-based study, with national repre-
sentativeness and a wide age bracket, allows a better patient
characterization.
For future research we consider to be relevant the inclusion of
emergency services data.
Conclusion
The relevance of this study lies on the production of scientific
evidence regarding multimorbidity and healthcare use in Portugal.
This evidence may substantiate the discussion about the possible
need for the Portuguese health system to adapt to these patients,
with changes in policies that will allow better and more efficient
treatment, as an individual healthcare plan for patients with
multiple conditions.
Supplementary data
Supplementary data are available at EURPUB online.
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Key points
 The management of patients with multimorbidity is
complex, these patients have greater healthcare needs,
which represent a heavy burden to health systems.
 Patients with multimorbidity have more primary care visits,
more medical or surgical specialist consultations and more
hospitalizations.
 Further discussion on policy change is needed, targeting a
more efficient treatment of these patients.
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